Literature DB >> 35039334

Control of Memory Phenotype T Lymphocyte Homeostasis: Role of Costimulation.

Abir K Panda1, Yong-Hee Kim1, Ethan M Shevach2.   

Abstract

Foxp3+ T regulatory cells (Tregs), CD4+Foxp3- T cells, and CD8+ T cells are composed of naive phenotype (NP) and memory phenotype (MP) subsets. Ten to 20% of each MP T cell population are cycling (Ki-67+) in vivo. We investigated the contribution of costimulatory (CD28) and coinhibitory (CTLA-4, PD-1) receptors on MP T cell homeostatic proliferation in vivo in the mouse. Blockade of CD28-CD80/CD86 signaling completely abolished MP Tregs and profoundly inhibited MP CD4+Foxp3- T cell proliferation, but it did not affect MP CD8+ T cell proliferation. Marked enhancement of homeostatic proliferation of MP Tregs and MP CD4+Foxp3- T cells was seen after blocking CTLA4-CD80/CD86 interactions and PD-1-PD-L1/2 interactions, and greater enhancement was seen with blockade of both pathways. The CD28 pathway also played an important role in the expansion of Tregs and MP T cells after treatment of mice with agonistic Abs to members of the TNF receptor superfamily, which can act directly (anti-GITR, anti-OX40, anti-4-1BB) or indirectly (anti-CD40) on T cells. Induction of a cytokine storm by blocking the interaction of NK inhibitory receptors with MHC class I had no effect on Treg homeostasis, enhanced MP CD4+ proliferation, and expansion in a CD28-dependent manner, but it enhanced MP CD8+ T cell proliferation in a CD28-independent manner. Because MP T cells exert potent biologic effects primarily before the induction of adaptive immune responses, these findings have important implications for the use of biologic agents designed to suppress autoimmune disease or enhance T effector function in cancer that may have negative effects on MP T cells.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35039334      PMCID: PMC8820589          DOI: 10.4049/jimmunol.2100653

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.426


  34 in total

1.  TCR signaling events are required for maintaining CD4 regulatory T cell numbers and suppressive capacities in the periphery.

Authors:  Arnaud Delpoux; Philippe Yakonowsky; Aurélie Durand; Céline Charvet; Michael Valente; Arnaud Pommier; Nelly Bonilla; Bruno Martin; Cédric Auffray; Bruno Lucas
Journal:  J Immunol       Date:  2014-11-07       Impact factor: 5.422

Review 2.  Normal T cell homeostasis: the conversion of naive cells into memory-phenotype cells.

Authors:  Jonathan Sprent; Charles D Surh
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

Review 3.  TNF-receptor superfamily agonists as molecular adjuvants for cancer vaccines.

Authors:  Timothy Nj Bullock
Journal:  Curr Opin Immunol       Date:  2017-07-24       Impact factor: 7.486

Review 4.  The role of interleukin-2 during homeostasis and activation of the immune system.

Authors:  Onur Boyman; Jonathan Sprent
Journal:  Nat Rev Immunol       Date:  2012-02-17       Impact factor: 53.106

5.  Continuous requirement for the TCR in regulatory T cell function.

Authors:  Andrew G Levine; Aaron Arvey; Wei Jin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2014-09-28       Impact factor: 25.606

6.  A 33D1+ Dendritic Cell/Autoreactive CD4+ T Cell Circuit Maintains IL-2-Dependent Regulatory T Cells in the Spleen.

Authors:  J Michael Stolley; Daniel J Campbell
Journal:  J Immunol       Date:  2016-08-26       Impact factor: 5.422

7.  Interleukin 2 plays a central role in Th2 differentiation.

Authors:  Javier Cote-Sierra; Gilles Foucras; Liying Guo; Lynda Chiodetti; Howard A Young; Jane Hu-Li; Jinfang Zhu; William E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-05       Impact factor: 11.205

8.  CTLA4 expression is an indicator and regulator of steady-state CD4+ FoxP3+ T cell homeostasis.

Authors:  Anita L Tang; John R Teijaro; Modesta N Njau; Smita S Chandran; Agnes Azimzadeh; Steven G Nadler; David M Rothstein; Donna L Farber
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

9.  PD-1 Primarily Targets TCR Signal in the Inhibition of Functional T Cell Activation.

Authors:  Reina Mizuno; Daisuke Sugiura; Kenji Shimizu; Takumi Maruhashi; Mizuki Watada; Il-Mi Okazaki; Taku Okazaki
Journal:  Front Immunol       Date:  2019-03-29       Impact factor: 7.561

Review 10.  Characteristics and clinical trial results of agonistic anti-CD40 antibodies in the treatment of malignancies.

Authors:  Da-Ke Li; Wen Wang
Journal:  Oncol Lett       Date:  2020-08-31       Impact factor: 2.967

View more
  1 in total

Review 1.  Memory-phenotype CD4+ T Lymphocytes: A Novel Therapeutic Target in Infectious or Autoimmune Diseases?

Authors:  Takeshi Kawabe
Journal:  JMA J       Date:  2022-06-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.